AMORPHOUS FORM OF TELOTRISTAT ETIPRATE
The present invention relates to amorphous forms of telotristat etiprate, to processes for preparing them, to pharmaceutical compositions comprising them, and to their medical use for the treatment of serotonin-mediated diseases or disorders.